CAMBRIDGE, Mass., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of…
- In vivo data presented at ASH Annual Meeting demonstrated strong antitumor activity against human lymphoma cell lines with CNTY-101…
CLN-081 continues to demonstrate a differentiated clinical profile at the recommended Phase 2 dose of 100mg BID Continued high response…
– DSMB evaluated both safety and efficacy data in recommending cohort progression – – Data from third patient cohort confirm…
GATINEAU, Quebec, Dec. 16, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NASDAQ: HEXO) today announced…
2022 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Silent period11 January 2022Annual report 20218…
Correction – Admission Date for New Ordinary Shares Included This announcement contains inside information for the purposes of Article 7…
VANCOUVER, British Columbia, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment or the (“Company”) (CSE: TRUE • OTC:…
Toronto, Ontario--(Newsfile Corp. - December 16, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its…
Toronto, Ontario--(Newsfile Corp. - December 16, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or…